National Academies Press: OpenBook
« Previous: CONTENTS
Suggested Citation:"INTRODUCTION." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World

INTRODUCTION

The three vaccines discussed in this report target diseases that are responsible for a significant amount of disease and death in developing nations. Unfortunately, as participants in the workshop learned, there is a dearth of good epidemiologic data in many poorer regions of the world. This not only makes it hard for researchers to design vaccines appropriate for a particular population, it also makes it hard to sell the benefits of vaccination to developing-country health ministries. Without convincing evidence of an infectious-disease problem, they are unlikely to favor spending scarce government funds on prevention.

Even were such disease information available, there may be considerable technical and scientific barriers preventing a potentially useful vaccine from reaching those who could benefit from its use. The conjugation process employed to make the three vaccines considered by this workshop is complex, requiring significant technical skill and advanced manufacturing capability. Both are in short supply in the developing world. Workshop participants learned of several alternatives to the standard randomized placebo-controlled study that may, in certain situations, provide useful efficacy data. The public and private sectors have worked and will continue to work together in various aspects of vaccine development, including clinical testing, although the incentives and expectations in each sector may differ markedly.

Perhaps the major barrier to the introduction of new vaccines against acute respiratory infections (ARI) and meningococcal pathogens is cost. For example, in the case of conjugate vaccine against Haemophilus influenzae type b (Hib), which has been shown highly effective over the last 5 years in children in

Suggested Citation:"INTRODUCTION." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 1
Next: ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD »
The Children's Vaccine Initiative: Continuing Activities Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!